Drachman Jonathan G
- SEC CIK
- 0001588467
No open-market purchases or sales filed in the past year.
Current role at each company
- HARP Harpoon Therapeutics, Inc.Directoras of Mar 11, 2024
- NGNE Neurogene Inc.President and CEOas of Aug 4, 2022
- CALA Calithera Biosciences, Inc.Directoras of Nov 10, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Drachman Jonathan G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CALA Calithera Biosciences, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 (view filing) | Nov 10 | Same day | Drachman Jonathan GDirector | PPurchase | +200.0K | $0.86 | +$172.0K | New position200.0K after |
NGNE Neurogene Inc.
President and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2021 (view filing) | Aug 24 | 2 days | Drachman Jonathan GPresident and CEO | PPurchase | +100.0K | $6.11 | +$611.0K | +4.4%2.35M after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Drachman Jonathan GPresident and CEO | PPurchase | +50.0K | $6.45 | +$322.5K | New position25.0K after | 2 lots |